Fig. 6.
CD19-specific T cells proliferate in response to stimulation by CD19+ B-ALL and lymphoma cells.
T cells (1 × 105) from a CD19-specific CD8+CTL clone were cocultured with 2 × 106 irradiated PBMCs. Some cultures received 1 × 105 irradiated CD19+ or CD19− stimulator cells. The 2 × 106 irradiated PBMCs and irradiated stimulator cells, at a 1:1 ratio with the T cells, were re-added after 7 days. One culture condition was the T-cell clone incubated without PBMCs and stimulator cells. Each culture condition was supplemented with 5 U/mL rhIL-2 every 48 hours. The cells were counted after 14 days and nonviable cells excluded by trypan blue staining. The average cell counts and SDs from 3 repeats are presented. In the insert, 105 T cells from a CD19-specific CD8+ CTL clone were cocultured as above. Methyl-[3H]thymidine was added after 96 hours and the incorporated counts were measured 18 hours later. The background incorporation of [3H]thymidine by Daudi cells and a LCL was 827 ± 358 and 909 ± 493, respectively. The average cell counts and SDs from triplicates are presented.